United States Orally Disintegrating Tablet Industry 2017 Market Research Report

Published: Apr, 2017 | Pages: 101 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the United States Orally Disintegrating Tablet market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Orally Disintegrating Tablet in these regions, from 2012 to 2022 (forecast).

United States Orally Disintegrating Tablet market competition by top manufacturers/players, with Orally Disintegrating Tablet sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer Inc
    Eli Lilly and Company
    Merck & Co., Inc
    AstraZeneca
    Bristol-Myers Squibb Company
    GlaxoSmithKline plc
    Johnson and Johnson
    Mission Pharmacal Company
    Sciele Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Tablet
    Capsule
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Orally Disintegrating Tablet for each application, including
    Central Nervous System Diseases (CNS)
    Gastrointestinal Diseases
    Oncology

 Table of Contents

United States Orally Disintegrating Tablet Market Report 2017
1 Orally Disintegrating Tablet Overview
    1.1 Product Overview and Scope of Orally Disintegrating Tablet
    1.2 Classification of Orally Disintegrating Tablet by Product Category
        1.2.1 United States Orally Disintegrating Tablet Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Orally Disintegrating Tablet Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Tablet
        1.2.4 Capsule
    1.3 United States Orally Disintegrating Tablet Market by Application/End Users
        1.3.1 United States Orally Disintegrating Tablet Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Central Nervous System Diseases (CNS)
        1.3.3 Gastrointestinal Diseases
        1.3.4 Oncology
    1.4 United States Orally Disintegrating Tablet Market by Region
        1.4.1 United States Orally Disintegrating Tablet Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Orally Disintegrating Tablet Status and Prospect (2012-2022)
        1.4.3 Southwest Orally Disintegrating Tablet Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Orally Disintegrating Tablet Status and Prospect (2012-2022)
        1.4.5 New England Orally Disintegrating Tablet Status and Prospect (2012-2022)
        1.4.6 The South Orally Disintegrating Tablet Status and Prospect (2012-2022)
        1.4.7 The Midwest Orally Disintegrating Tablet Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Orally Disintegrating Tablet (2012-2022)
        1.5.1 United States Orally Disintegrating Tablet Sales and Growth Rate (2012-2022)
        1.5.2 United States Orally Disintegrating Tablet Revenue and Growth Rate (2012-2022)

2 United States Orally Disintegrating Tablet Market Competition by Players/Suppliers
    2.1 United States Orally Disintegrating Tablet Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Orally Disintegrating Tablet Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Orally Disintegrating Tablet Average Price by Players/Suppliers (2012-2017)
    2.4 United States Orally Disintegrating Tablet Market Competitive Situation and Trends
        2.4.1 United States Orally Disintegrating Tablet Market Concentration Rate
        2.4.2 United States Orally Disintegrating Tablet Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Orally Disintegrating Tablet Manufacturing Base Distribution, Sales Area, Product Type

3 United States Orally Disintegrating Tablet Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Orally Disintegrating Tablet Sales and Market Share by Region (2012-2017)
    3.2 United States Orally Disintegrating Tablet Revenue and Market Share by Region (2012-2017)
    3.3 United States Orally Disintegrating Tablet Price by Region (2012-2017)

4 United States Orally Disintegrating Tablet Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Orally Disintegrating Tablet Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Orally Disintegrating Tablet Revenue and Market Share by Type (2012-2017)
    4.3 United States Orally Disintegrating Tablet Price by Type (2012-2017)
    4.4 United States Orally Disintegrating Tablet Sales Growth Rate by Type (2012-2017)

5 United States Orally Disintegrating Tablet Sales (Volume) by Application (2012-2017)
    5.1 United States Orally Disintegrating Tablet Sales and Market Share by Application (2012-2017)
    5.2 United States Orally Disintegrating Tablet Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Orally Disintegrating Tablet Players/Suppliers Profiles and Sales Data
    6.1 Pfizer Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Orally Disintegrating Tablet Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Inc Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Eli Lilly and Company
        6.2.2 Orally Disintegrating Tablet Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merck & Co., Inc
        6.3.2 Orally Disintegrating Tablet Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck & Co., Inc Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 AstraZeneca
        6.4.2 Orally Disintegrating Tablet Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 AstraZeneca Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bristol-Myers Squibb Company
        6.5.2 Orally Disintegrating Tablet Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bristol-Myers Squibb Company Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 GlaxoSmithKline plc
        6.6.2 Orally Disintegrating Tablet Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 GlaxoSmithKline plc Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Johnson and Johnson
        6.7.2 Orally Disintegrating Tablet Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Mission Pharmacal Company
        6.8.2 Orally Disintegrating Tablet Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Mission Pharmacal Company Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Sciele Pharma
        6.9.2 Orally Disintegrating Tablet Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Sciele Pharma Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Orally Disintegrating Tablet Manufacturing Cost Analysis
    7.1 Orally Disintegrating Tablet Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Orally Disintegrating Tablet

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Orally Disintegrating Tablet Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Orally Disintegrating Tablet Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Orally Disintegrating Tablet Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Orally Disintegrating Tablet Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Orally Disintegrating Tablet Sales Volume Forecast by Type (2017-2022)
    11.3 United States Orally Disintegrating Tablet Sales Volume Forecast by Application (2017-2022)
    11.4 United States Orally Disintegrating Tablet Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Orally Disintegrating Tablet
    Figure United States Orally Disintegrating Tablet Market Size (K Pcs) by Type (2012-2022)
    Figure United States Orally Disintegrating Tablet Sales Volume Market Share by Type (Product Category) in 2016
    Figure Tablet Product Picture
    Figure Capsule Product Picture
    Figure United States Orally Disintegrating Tablet Market Size (K Pcs) by Application (2012-2022)
    Figure United States Sales Market Share of Orally Disintegrating Tablet by Application in 2016
    Figure Central Nervous System Diseases (CNS) Examples
    Figure Gastrointestinal Diseases Examples
    Figure Oncology Examples
    Figure United States Orally Disintegrating Tablet Market Size (Million USD) by Region (2012-2022)
    Figure The West Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southwest Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Middle Atlantic Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2012-2022)
    Figure New England Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The South of US Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Midwest Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Orally Disintegrating Tablet Sales (K Pcs) and Growth Rate (2012-2022)
    Figure United States Orally Disintegrating Tablet Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Orally Disintegrating Tablet Market Major Players Product Sales Volume (K Pcs) (2012-2017)
    Table United States Orally Disintegrating Tablet Sales (K Pcs) of Key Players/Suppliers (2012-2017)
    Table United States Orally Disintegrating Tablet Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Orally Disintegrating Tablet Sales Share by Players/Suppliers
    Figure 2017 United States Orally Disintegrating Tablet Sales Share by Players/Suppliers
    Figure United States Orally Disintegrating Tablet Market Major Players Product Revenue (Million USD) (2012-2017)
    Table United States Orally Disintegrating Tablet Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table United States Orally Disintegrating Tablet Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Orally Disintegrating Tablet Revenue Share by Players/Suppliers
    Figure 2017 United States Orally Disintegrating Tablet Revenue Share by Players/Suppliers
    Table United States Market Orally Disintegrating Tablet Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
    Figure United States Market Orally Disintegrating Tablet Average Price (USD/Pcs) of Key Players/Suppliers in 2016
    Figure United States Orally Disintegrating Tablet Market Share of Top 3 Players/Suppliers
    Figure United States Orally Disintegrating Tablet Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Orally Disintegrating Tablet Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Orally Disintegrating Tablet Product Category
    Table United States Orally Disintegrating Tablet Sales (K Pcs) by Region (2012-2017)
    Table United States Orally Disintegrating Tablet Sales Share by Region (2012-2017)
    Figure United States Orally Disintegrating Tablet Sales Share by Region (2012-2017)
    Figure United States Orally Disintegrating Tablet Sales Market Share by Region in 2016
    Table United States Orally Disintegrating Tablet Revenue (Million USD) and Market Share by Region (2012-2017)
    Table United States Orally Disintegrating Tablet Revenue Share by Region (2012-2017)
    Figure United States Orally Disintegrating Tablet Revenue Market Share by Region (2012-2017)
    Figure United States Orally Disintegrating Tablet Revenue Market Share by Region in 2016
    Table United States Orally Disintegrating Tablet Price (USD/Pcs) by Region (2012-2017)
    Table United States Orally Disintegrating Tablet Sales (K Pcs) by Type (2012-2017)
    Table United States Orally Disintegrating Tablet Sales Share by Type (2012-2017)
    Figure United States Orally Disintegrating Tablet Sales Share by Type (2012-2017)
    Figure United States Orally Disintegrating Tablet Sales Market Share by Type in 2016
    Table United States Orally Disintegrating Tablet Revenue  (Million USD) and Market Share by Type (2012-2017)
    Table United States Orally Disintegrating Tablet Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Orally Disintegrating Tablet by Type (2012-2017)
    Figure Revenue Market Share of Orally Disintegrating Tablet by Type in 2016
    Table United States Orally Disintegrating Tablet Price (USD/Pcs) by Types (2012-2017)
    Figure United States Orally Disintegrating Tablet Sales Growth Rate by Type (2012-2017)
    Table United States Orally Disintegrating Tablet Sales (K Pcs) by Application (2012-2017)
    Table United States Orally Disintegrating Tablet Sales Market Share by Application (2012-2017)
    Figure United States Orally Disintegrating Tablet Sales Market Share by Application (2012-2017)
    Figure United States Orally Disintegrating Tablet Sales Market Share by Application in 2016
    Table United States Orally Disintegrating Tablet Sales Growth Rate by Application (2012-2017)
    Figure United States Orally Disintegrating Tablet Sales Growth Rate by Application (2012-2017)
    Table Pfizer Inc Basic Information List
    Table Pfizer Inc Orally Disintegrating Tablet Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Pfizer Inc Orally Disintegrating Tablet Sales Growth Rate (2012-2017)
    Figure Pfizer Inc Orally Disintegrating Tablet Sales Market Share in United States (2012-2017)
    Figure Pfizer Inc Orally Disintegrating Tablet Revenue Market Share in United States (2012-2017)
    Table Eli Lilly and Company Basic Information List
    Table Eli Lilly and Company Orally Disintegrating Tablet Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Eli Lilly and Company Orally Disintegrating Tablet Sales Growth Rate (2012-2017)
    Figure Eli Lilly and Company Orally Disintegrating Tablet Sales Market Share in United States (2012-2017)
    Figure Eli Lilly and Company Orally Disintegrating Tablet Revenue Market Share in United States (2012-2017)
    Table Merck & Co., Inc Basic Information List
    Table Merck & Co., Inc Orally Disintegrating Tablet Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Merck & Co., Inc Orally Disintegrating Tablet Sales Growth Rate (2012-2017)
    Figure Merck & Co., Inc Orally Disintegrating Tablet Sales Market Share in United States (2012-2017)
    Figure Merck & Co., Inc Orally Disintegrating Tablet Revenue Market Share in United States (2012-2017)
    Table AstraZeneca Basic Information List
    Table AstraZeneca Orally Disintegrating Tablet Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure AstraZeneca Orally Disintegrating Tablet Sales Growth Rate (2012-2017)
    Figure AstraZeneca Orally Disintegrating Tablet Sales Market Share in United States (2012-2017)
    Figure AstraZeneca Orally Disintegrating Tablet Revenue Market Share in United States (2012-2017)
    Table Bristol-Myers Squibb Company Basic Information List
    Table Bristol-Myers Squibb Company Orally Disintegrating Tablet Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Bristol-Myers Squibb Company Orally Disintegrating Tablet Sales Growth Rate (2012-2017)
    Figure Bristol-Myers Squibb Company Orally Disintegrating Tablet Sales Market Share in United States (2012-2017)
    Figure Bristol-Myers Squibb Company Orally Disintegrating Tablet Revenue Market Share in United States (2012-2017)
    Table GlaxoSmithKline plc Basic Information List
    Table GlaxoSmithKline plc Orally Disintegrating Tablet Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure GlaxoSmithKline plc Orally Disintegrating Tablet Sales Growth Rate (2012-2017)
    Figure GlaxoSmithKline plc Orally Disintegrating Tablet Sales Market Share in United States (2012-2017)
    Figure GlaxoSmithKline plc Orally Disintegrating Tablet Revenue Market Share in United States (2012-2017)
    Table Johnson and Johnson Basic Information List
    Table Johnson and Johnson Orally Disintegrating Tablet Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Johnson and Johnson Orally Disintegrating Tablet Sales Growth Rate (2012-2017)
    Figure Johnson and Johnson Orally Disintegrating Tablet Sales Market Share in United States (2012-2017)
    Figure Johnson and Johnson Orally Disintegrating Tablet Revenue Market Share in United States (2012-2017)
    Table Mission Pharmacal Company Basic Information List
    Table Mission Pharmacal Company Orally Disintegrating Tablet Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Mission Pharmacal Company Orally Disintegrating Tablet Sales Growth Rate (2012-2017)
    Figure Mission Pharmacal Company Orally Disintegrating Tablet Sales Market Share in United States (2012-2017)
    Figure Mission Pharmacal Company Orally Disintegrating Tablet Revenue Market Share in United States (2012-2017)
    Table Sciele Pharma Basic Information List
    Table Sciele Pharma Orally Disintegrating Tablet Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Sciele Pharma Orally Disintegrating Tablet Sales Growth Rate (2012-2017)
    Figure Sciele Pharma Orally Disintegrating Tablet Sales Market Share in United States (2012-2017)
    Figure Sciele Pharma Orally Disintegrating Tablet Revenue Market Share in United States (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Orally Disintegrating Tablet
    Figure Manufacturing Process Analysis of Orally Disintegrating Tablet
    Figure Orally Disintegrating Tablet Industrial Chain Analysis
    Table Raw Materials Sources of Orally Disintegrating Tablet Major Players/Suppliers in 2016
    Table Major Buyers of Orally Disintegrating Tablet
    Table Distributors/Traders List
    Figure United States Orally Disintegrating Tablet Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure United States Orally Disintegrating Tablet Revenue  (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Orally Disintegrating Tablet Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Orally Disintegrating Tablet Sales Volume (K Pcs) Forecast by Type (2017-2022)
    Figure United States Orally Disintegrating Tablet Sales Volume (K Pcs) Forecast by Type (2017-2022)
    Figure United States Orally Disintegrating Tablet Sales Volume (K Pcs) Forecast by Type in 2022
    Table United States Orally Disintegrating Tablet Sales Volume (K Pcs) Forecast by Application (2017-2022)
    Figure United States Orally Disintegrating Tablet Sales Volume (K Pcs) Forecast by Application (2017-2022)
    Figure United States Orally Disintegrating Tablet Sales Volume (K Pcs) Forecast by Application in 2022
    Table United States Orally Disintegrating Tablet Sales Volume (K Pcs) Forecast by Region (2017-2022)
    Table United States Orally Disintegrating Tablet Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Orally Disintegrating Tablet Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Orally Disintegrating Tablet Sales Volume Share Forecast by Region in 2022
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.